Aspen Neuroscience, Inc. ASPE
IPO
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -- | -- | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -- | -- | |||
| Operating Income | -- | -- | |||
| Income Before Tax | -- | -- | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -- | -- | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -- | -- | |||
| EBIT | -- | -- | |||
| EBITDA | -- | -- | |||
| EPS Basic | -1.74 | -1.63 | |||
| Normalized Basic EPS | -1.09 | -1.02 | |||
| EPS Diluted | -1.74 | -1.63 | |||
| Normalized Diluted EPS | -1.09 | -1.02 | |||
| Average Basic Shares Outstanding | 10.94M | 10.69M | |||
| Average Diluted Shares Outstanding | 10.94M | 10.69M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||